← United States · Coverage record
US · SEC FORM 4
PROTHENA CORP PUBLIC LTD CO
PRTA · Nasdaq · CIK 0001559053 · Healthcare · Biotechnology
INSIDER SIGNAL
1 buyers · 17 purchase transaction lines · $10.9M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
- ✓ Recent activity · latest purchase 2026-10-14
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 62.9
- 62.8
- 62.6
- 63.6
- 63.2
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -1.3%
- 3M
- -3.7%
- 6M
- -23.4%
- 12M
- -21.7%
Volatility & liquidity
- Volatility
- 64.3%
- Beta
- —
- Avg daily value
- USD 4.1M
Valuation
- Market cap
- —
- P/E
- —
Fundamentals
- Profit margin
- —
- ROE
- -87.0%
- Industry
- Biotechnology
Market data
Price data up to: 2026-10-18 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: ROE · Fiscal year ended: 2025-12-31 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 8,010,864
- Previous report
- 8,544,664
- Avg daily volume
- 580,885
- Days to cover
- 13.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 10,000 | USD 8.46 | USD 84,569 | SEC filing ↗ |
| 2026-10-13 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 100,000 | USD 8.35 | USD 835,480 | SEC filing ↗ |
| 2026-10-08 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 90,000 | USD 8.57 | USD 770,904 | SEC filing ↗ |
| 2026-10-07 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 125,000 | USD 8.40 | USD 1,050,150 | SEC filing ↗ |
| 2026-10-02 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 100,000 | USD 8.57 | USD 857,240 | SEC filing ↗ |
| 2026-09-29 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 162,000 | USD 8.68 | USD 1,406,160 | SEC filing ↗ |
| 2026-09-28 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 103,500 | USD 8.60 | USD 890,100 | SEC filing ↗ |
| 2026-09-18 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 100,000 | USD 8.43 | USD 843,000 | SEC filing ↗ |
| 2026-09-02 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 27,000 | USD 9.47 | USD 255,690 | SEC filing ↗ |
| 2026-08-20 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 50,000 | USD 8.79 | USD 439,500 | SEC filing ↗ |
| 2026-08-07 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 37,500 | USD 8.62 | USD 323,250 | SEC filing ↗ |
| 2026-06-16 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 20,000 | USD 7.90 | USD 158,000 | SEC filing ↗ |
| 2026-06-11 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 125,000 | USD 8.17 | USD 1,021,250 | SEC filing ↗ |
| 2026-06-04 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 50,000 | USD 9.31 | USD 465,500 | SEC filing ↗ |
| 2026-06-02 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 50,000 | USD 9.43 | USD 471,500 | SEC filing ↗ |
Form 4 evidence
38 transaction lines in the latest 365-day window; 472 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 10,000 | USD 8.46 | USD 84,569 | SEC filing ↗ |
| 2026-10-13 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 100,000 | USD 8.35 | USD 835,480 | SEC filing ↗ |
| 2026-10-08 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 90,000 | USD 8.57 | USD 770,904 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 10,000 | USD 8.46 | USD 84,569 | SEC filing ↗ |
| 2026-10-13 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 100,000 | USD 8.35 | USD 835,480 | SEC filing ↗ |
| 2026-10-08 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 90,000 | USD 8.57 | USD 770,904 | SEC filing ↗ |
| 2026-10-07 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 125,000 | USD 8.40 | USD 1,050,150 | SEC filing ↗ |
| 2026-10-02 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 100,000 | USD 8.57 | USD 857,240 | SEC filing ↗ |
| 2026-09-29 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 162,000 | USD 8.68 | USD 1,406,160 | SEC filing ↗ |
| 2026-09-28 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 103,500 | USD 8.60 | USD 890,100 | SEC filing ↗ |
| 2026-09-18 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 100,000 | USD 8.43 | USD 843,000 | SEC filing ↗ |
| 2026-09-02 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 27,000 | USD 9.47 | USD 255,690 | SEC filing ↗ |
| 2026-08-20 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 50,000 | USD 8.79 | USD 439,500 | SEC filing ↗ |
| 2026-08-18 | SCULLY WILLIAM P | Gift (G) | Ordinary Shares, par value $0.01 per share | 627,553 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-17 | SCULLY WILLIAM P | Gift (G) | Ordinary Shares, par value $0.01 per share | 336,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-10 | SCULLY WILLIAM P | Gift (G) | Ordinary Shares, par value $0.01 per share | 251,553 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-07 | SCULLY WILLIAM P | Purchase (P) | Ordinary Shares, par value $0.01 per share | 37,500 | USD 8.62 | USD 323,250 | SEC filing ↗ |
| 2026-07-29 | Kingston Anne Evans | Sale (S) | Ordinary Shares, par value $0.01 per share | 7,662 | USD 8.47 | USD 64,897 | SEC filing ↗ |
| 2026-07-29 | Isaacs Michael John | Sale (S) | Ordinary Shares, par value $0.01 per share | 8,386 | USD 8.47 | USD 71,029 | SEC filing ↗ |
| 2026-07-28 | Zago Wagner M. | Option exercise / conversion (M) | Ordinary Shares, par value $0.01 per share | 51,000 | USD — | USD — | SEC filing ↗ |
| 2026-07-28 | Zago Wagner M. | D (D) | Ordinary Shares, par value $0.01 per share | 51,000 | USD 8.56 | USD 436,560 | SEC filing ↗ |
| 2026-07-28 | Walker Karin L | Option exercise / conversion (M) | Ordinary Shares, par value $0.01 per share | 15,000 | USD — | USD — | SEC filing ↗ |
| 2026-07-28 | Walker Karin L | D (D) | Ordinary Shares, par value $0.01 per share | 15,000 | USD 8.56 | USD 128,400 | SEC filing ↗ |
| 2026-07-28 | Swanson Chad J. | Option exercise / conversion (M) | Ordinary Shares, par value $0.01 per share | 51,000 | USD — | USD — | SEC filing ↗ |
| 2026-07-28 | Swanson Chad J. | Tax withholding (F) | Ordinary Shares, par value $0.01 per share | 3,467 | USD 8.56 | USD 29,678 | SEC filing ↗ |
| 2026-07-28 | Swanson Chad J. | D (D) | Ordinary Shares, par value $0.01 per share | 40,800 | USD 8.56 | USD 349,248 | SEC filing ↗ |
| 2026-07-28 | Smith Brandon S. | Option exercise / conversion (M) | Ordinary Shares, par value $0.01 per share | 78,000 | USD — | USD — | SEC filing ↗ |
| 2026-07-28 | Smith Brandon S. | D (D) | Ordinary Shares, par value $0.01 per share | 78,000 | USD 8.56 | USD 667,680 | SEC filing ↗ |
| 2026-07-28 | Nguyen Tran | Option exercise / conversion (M) | Ordinary Shares, par value $0.01 per share | 57,000 | USD — | USD — | SEC filing ↗ |
| 2026-07-28 | Nguyen Tran | D (D) | Ordinary Shares, par value $0.01 per share | 57,000 | USD 8.56 | USD 487,920 | SEC filing ↗ |
| 2026-07-28 | Kinney Gene G. | Option exercise / conversion (M) | Ordinary Shares, par value $0.01 per share | 84,000 | USD — | USD — | SEC filing ↗ |
| 2026-07-28 | Kinney Gene G. | D (D) | Ordinary Shares, par value $0.01 per share | 84,000 | USD 8.56 | USD 719,040 | SEC filing ↗ |
| 2026-07-28 | Kingston Anne Evans | Tax withholding (F) | Ordinary Shares, par value $0.01 per share | 3,498 | USD 8.56 | USD 29,943 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | PRTA |
| CIK | 0001559053 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 472 transaction lines from 2020-04-08 to 2026-10-14 34 P purchase lines · 282 S sale lines · 156 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.